TNFSF10 and pancreatic neoplasm: Alternatively, ABT-737 has been reported to potentiate the TRAIL-induced apoptosis of human pancreatic cancer cells by conformationally changing Bax and disrupting the binding of Bak with Bcl-xL [43].